Department of Orthopaedic, Huizhou First Hospital, Guangdong Medical University, Huizhou, 516003, Guangdong, China.
Guangdong Medical University, DongGuan, 523000, Guangdong, China.
Tissue Eng Regen Med. 2023 Oct;20(6):981-992. doi: 10.1007/s13770-023-00561-w. Epub 2023 Sep 12.
Implantation of bone marrow mesenchymal stem cells (BMSCs) is a potential alternative for promoting bone defects healing or osseointegration in osteoporosis. However, the reactive oxygen species (ROS) accumulated and excessive inflammation in the osteoporotic microenvironment could weaken the self-replication and multi-directional differentiation of transplanted BMSCs.
In this study, to improve the hostile microenvironment in osteoporosis, Poloxamer 407 and hyaluronic acid (HA) was crosslinked to synthetize a thermos-responsive and injectable hydrogel to load MnO nanoparticles as a protective carrier (MnO@Pol/HA hydrogel) for delivering BMSCs.
The resulting MnO@Pol/HA hydrogel processed excellent biocompatibility and durable retention time, and can eliminate accumulated ROS effectively, thereby protecting BMSCs from ROS-mediated inhibition of cell viability, including survival, proliferation, and osteogenic differentiation. In osteoporotic bone defects, implanting of this BMSCs incorporated MnO@Pol/HA hydrogel significantly eliminated ROS level in bone marrow and bone tissue, induced macrophages polarization from M1 to M2 phenotype, decreased the expression of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, and IL-6) and osteogenic related factors (e.g., TGF-β and PDGF).
This hydrogel-based BMSCs protected delivery strategy indicated better bone repair effect than BMSCs delivering or MnO@Pol/HA hydrogel implantation singly, which providing a potential alternative strategy for enhancing osteoporotic bone defects healing.
骨髓间充质干细胞(BMSCs)的植入是促进骨质疏松症中骨缺损愈合或骨整合的一种潜在替代方法。然而,骨质疏松症微环境中积累的活性氧(ROS)和过度炎症会削弱移植的 BMSCs 的自我复制和多向分化能力。
在这项研究中,为了改善骨质疏松症中的恶劣微环境,将泊洛沙姆 407 和透明质酸(HA)交联以合成一种热响应性和可注射的水凝胶,以装载 MnO 纳米颗粒作为保护性载体(MnO@Pol/HA 水凝胶)来递送 BMSCs。
所得的 MnO@Pol/HA 水凝胶具有出色的生物相容性和持久的保留时间,并且可以有效消除积累的 ROS,从而保护 BMSCs 免受 ROS 介导的细胞活力抑制,包括存活、增殖和成骨分化。在骨质疏松性骨缺损中,植入这种包含 BMSCs 的 MnO@Pol/HA 水凝胶可显著消除骨髓和骨组织中的 ROS 水平,诱导巨噬细胞从 M1 表型向 M2 表型极化,降低促炎细胞因子(如 TNF-α、IL-1β 和 IL-6)和成骨相关因子(如 TGF-β和 PDGF)的表达。
这种基于水凝胶的 BMSCs 保护递送策略比单独递送 BMSCs 或植入 MnO@Pol/HA 水凝胶具有更好的骨修复效果,为增强骨质疏松性骨缺损愈合提供了一种潜在的替代策略。